$BYAH News

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering

Park Ha Biological Technology shares are trading lower. The company announced the pricing of a best-efforts follow-on public offering of 21,875,000 units at $0.112 per Unit.

Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering

Park Ha Biological Technology Prices $2.45M Follow-On Offering Of 21.875M Shares At $$0.00002/Share And 1 Warrant To Purchase Class A Ordinary Shares

Park Ha Biological Technology First Half 2025 Earnings: US$0.74 loss per share (vs US$0.002 profit in 1H 2024)

Park Ha Biological Technology Co., Ltd.'s (NASDAQ:PHH) most bullish insider is CEO Xiaoqiu Zhang, and their holdings value went up by 35% last week

Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025

Park Ha Biological Technology: Growth Potential And Profitability Concerns

Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025?

Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week

D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering

Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Park Ha Biological Aims For U.S. IPO At Sky-High Valuation